Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Assertio Therapeutics ( (ASRT) ) has shared an update.
On May 5, 2026, Assertio Holdings announced that it had mutually agreed with Garda Therapeutics to postpone to May 8, 2026 the commencement of the tender offer for all outstanding Assertio shares, tied to their amended and restated merger agreement under which Garda plans to acquire Assertio for $21.80 per share in cash, valuing the deal at about $153.2 million. The company also said it would delay until May 8, 2026 the start of the related tender offer for its outstanding Convertible Senior Notes, a timing shift that slightly extends the transaction timeline but keeps the path intact for Assertio’s planned acquisition and the associated change in ownership for shareholders and noteholders.
The most recent analyst rating on (ASRT) stock is a Buy with a $21.80 price target. To see the full list of analyst forecasts on Assertio Therapeutics stock, see the ASRT Stock Forecast page.
Spark’s Take on ASRT Stock
According to Spark, TipRanks’ AI Analyst, ASRT is a Neutral.
The score is held back primarily by weak financial performance (multi-year revenue declines, ongoing losses, and 2025 cash flow turning negative). Offsetting this are strong technical momentum and a significant positive corporate catalyst from the enhanced all-cash acquisition agreement, while valuation remains difficult to support due to negative earnings.
To see Spark’s full report on ASRT stock, click here.
More about Assertio Therapeutics
Assertio Holdings, Inc. is a pharmaceutical company with comprehensive commercial capabilities, marketing differentiated products designed to address patients’ needs. The company primarily focuses on the oncology market, leveraging its commercial platform to support cancer patients through specialized therapeutics and related offerings.
Average Trading Volume: 208,103
Technical Sentiment Signal: Hold
Current Market Cap: $139.3M
See more data about ASRT stock on TipRanks’ Stock Analysis page.